BioCopy chooses Genedata for AI-powered Multi-specific Antibody Discovery

Basel, July 17, 2024
By implementing the leading enterprise software solution for bio-pharmaceutical R&D, BioCopy takes the necessary step towards its AI-powered high-quality engineering of next-generation cancer therapeutics.